Strategic Acquisition Mathys is now part of Enovis since 2021, indicating access to larger distribution networks, capital, and a broader product portfolio. Leverage Enovis relationships and cross-sell joint replacement solutions, implants, and synthetic grafts to expand market reach.

Global Footprint Headquartered in Switzerland with development and production in Europe and subsidiaries in 10 countries, Mathys demonstrates a scalable international presence. Target expansions in markets where Enovis operates and identify distribution partners to accelerate growth.

Orthopedic Focus Specialization in hip, knee, shoulder, sports orthopedics, and bone graft substitutes positions Mathys as a turnkey supplier for implant portfolios and associated enabling technologies. Propose value-adds around surgical systems, accessories, and post-market support.

Mid-Market Opportunity Revenue is in the low-to-mid single-digit millions with 51-200 employees, suggesting a mid-market profile with potential needs for scalable manufacturing, regulatory support, and supply chain resilience. Offer modular manufacturing capacity, quality systems optimization, and regional supply assurances.

Digital & Compliance Readiness Existing tech stack includes cloud and enterprise tools; potential for data-driven partnerships, digital training platforms, and enhanced compliance/traceability solutions. Position offerings around digital workflow integration, CRM-enabled sales enablement, and cloud-based product lifecycle management.